CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-45.09%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$71.3M
AUM Growth
+$71.3M
(-56%)
Cap. Flow
-$26.7M
Cap. Flow
% of AUM
-37.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Surrozen
SRZN
|
$2.12M |
Top Sells
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$28.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenaya Therapeutics
TNYA
$184M
| $29.1M | 40.88% | 9,400,290 | – | – |
|
2
Oric Pharmaceuticals
ORIC
$994M
| $25M | 35.12% | 3,540,777 | – | – |
|
|
3
Surrozen
SRZN
$104M
| $8.87M | 12.44% | 810,088 +193,548 | +31% | +$2.12M |
|
4
RAPT Therapeutics
RAPT
$188M
| $8.18M | 11.47% | 2,680,621 | – | – |
|
5
Sagimet Biosciences
SGMT
$244M
| $58.7K | 0.08% | 17,169 | – | – |
|
6
Revolution Medicines
RVMD
$7.1B
| $1.79K | ﹤0.01% | 46 | – | – |
|
|
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – | -18,136,735 | Closed | -$28.8M |
|